<p>Kidney transplantation offers life-extending treatment for patients with end-stage renal disease, yet long-term risks of graft loss and death persist. Traditional prediction models using only baseline data often fail to capture patients’ evolving health status post-transplant. In this study, we propose a two-stage machine learning (ML) framework for dynamic, next-year risk prediction of graft loss and death, updated annually with newly available clinical and laboratory data. Using a multi-center cohort from the Swiss Transplant Cohort Study (STCS), we trained and evaluated five ML models across 13 years of follow-up, demonstrating that incorporating longitudinal data significantly improved predictive performance compared to baseline-only models. LightGBM achieved the strongest performance, with AUROC values up to 0.896 for graft loss and 0.797 for death. Our findings suggest that dynamic, interpretable ML models can enhance personalized risk stratification, offering a practical and scalable tool for guiding follow-up strategies and early interventions in kidney transplant recipients.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Enhancing post-kidney transplant prognostication: an interpretable machine learning approach for longitudinal outcome prediction

  • Bowen Fan,
  • Manuel Schürch,
  • Yuan Tian,
  • Anna Mallone,
  • Lukas Frischknecht,
  • Michael Koller,
  • Christian Van Delden,
  • Alexander Leichtle,
  • Dela Golshayan,
  • Jean Villard,
  • Thomas Schachtner,
  • Daniel Sidler,
  • Stefan Schaub,
  • Jakob Nilsson,
  • Michael Krauthammer,
  • Patrizia Amico,
  • Adrian Bachofner,
  • Vanessa Banz,
  • Sonja Beckmann,
  • Guido Beldi,
  • Christoph Berger,
  • Ekaterine Berishvili,
  • Annalisa Berzigotti,
  • Françoise-Isabelle Binet,
  • Pierre-Yves Bochud,
  • Petra Borner,
  • Sanda Branca,
  • Anne Cairoli,
  • Emmanuelle Catana,
  • Yves Chalandon,
  • Philippe Compagnon,
  • Sabina De Geest,
  • Sophie De Seigneux,
  • Michael Dickenmann,
  • Joëlle Lynn Dreifuss,
  • Thomas Fehr,
  • Sylvie Ferrari-Lacraz,
  • Andreas Flammer,
  • Jaromil Frossard,
  • Déla Golshayan,
  • Nicolas Goossens,
  • Fadi Haidar,
  • Jürg Halter,
  • Christoph Hess,
  • Sven Hillinger,
  • Hans Hirsch,
  • Patricia Hirt,
  • Linard Hoessly,
  • Uyen Huynh-Do,
  • Franz Immer,
  • Nina Khanna,
  • Angela Koutsokera,
  • Andreas Kremer,
  • Thorsten Krueger,
  • Christian Kuhn,
  • Arnaud L’Huillier,
  • Bettina Laesser,
  • Frédéric Lamoth,
  • Roger Lehmann,
  • Oriol Manuel,
  • Hans-Peter Marti,
  • Michele Martinelli,
  • Valérie McLin,
  • Katell Mellac,
  • Aurélia Merçay,
  • Karin Mettler,
  • Sara Christina Meyer,
  • Nicolas Müller,
  • Jelena Müller,
  • Ulrike Müller-Arndt,
  • Mirjam Nägeli,
  • Dionysios Neofytos,
  • Manuel Pascual,
  • Rosmarie Pazeller,
  • David Reineke,
  • Juliane Rick,
  • Fabian Rössler,
  • Silvia Rothlin,
  • Dominik Schneidawind,
  • Macé Schuurmans,
  • Simon Schwab,
  • Thierry Sengstag,
  • Federico Simonetta,
  • Jürg Steiger,
  • Guido Stirnimann,
  • Ueli Stürzinger,
  • Christian Van Delden,
  • Jean-Pierre Venetz,
  • Julien Vionnet,
  • Laura Walti,
  • Caroline Wehmeier,
  • Patrick Yerly

摘要

Kidney transplantation offers life-extending treatment for patients with end-stage renal disease, yet long-term risks of graft loss and death persist. Traditional prediction models using only baseline data often fail to capture patients’ evolving health status post-transplant. In this study, we propose a two-stage machine learning (ML) framework for dynamic, next-year risk prediction of graft loss and death, updated annually with newly available clinical and laboratory data. Using a multi-center cohort from the Swiss Transplant Cohort Study (STCS), we trained and evaluated five ML models across 13 years of follow-up, demonstrating that incorporating longitudinal data significantly improved predictive performance compared to baseline-only models. LightGBM achieved the strongest performance, with AUROC values up to 0.896 for graft loss and 0.797 for death. Our findings suggest that dynamic, interpretable ML models can enhance personalized risk stratification, offering a practical and scalable tool for guiding follow-up strategies and early interventions in kidney transplant recipients.